Modulo Bio, Inc.
Pharmaceutical company · Los Altos, California, United States
Modulo Bio, Inc. is a pharmaceutical company headquartered in Los Altos, California, United States. Its earliest recorded incorporation is in 2021. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2.9 million in total, most recently in 2023. It has reported private securities offerings to the US SEC, most recently $5.8 million sold in a notice filed in 2024.
Modulo Bio at a glance
What does Modulo Bio do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $2.9 million in total (2023). NIH funding came from the National Institute of Mental Health.
Private fundraising reported to the SEC
2 Form D notices; the most recent reported $5.8 million sold (2024).
Frequently asked questions about Modulo Bio
Where is Modulo Bio headquartered?
Modulo Bio, Inc. is headquartered in Los Altos, California, United States.
What does Modulo Bio do?
Modulo Bio, Inc. is a pharmaceutical company.
When was Modulo Bio founded?
The earliest incorporation on record for Modulo Bio, Inc. is in 2021, according to public company registers.
Similar companies
- Intekrin Therapeutics IncLos Altos, California, United States
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences